GLPG (Galapagos NV) Other Operating Expense : $-2.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Galapagos NV Other Operating Expense?

Galapagos NV's Other Operating Expense for the three months ended in Mar. 2025 was $-7.1 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-2.0 Mil.

Galapagos NV's quarterly Other Operating Expense increased from Sep. 2024 ($-28.3 Mil) to Dec. 2024 ($22.6 Mil) but then declined from Dec. 2024 ($22.6 Mil) to Mar. 2025 ($-7.1 Mil).

Galapagos NV's annual Other Operating Expense declined from Dec. 2022 ($-0.8 Mil) to Dec. 2023 ($-8.2 Mil) but then increased from Dec. 2023 ($-8.2 Mil) to Dec. 2024 ($-3.4 Mil).

Galapagos NV Other Operating Expense Historical Data

The historical data trend for Galapagos NV's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Other Operating Expense Chart

Galapagos NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

-30.42

276.89

-0.85

-8.24

-3.37

Galapagos NV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-10.20	10.83	-28.29	22.62	-7.13

Galapagos NV Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.0 Mil.

Galapagos NV Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (NAS:GLPG) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

GLPGF:USA GLPG:Netherlands GLPGa:UK 0JXZ:UK GXEA:Germany GXE:Germany GXEA:Germany GXE:Germany G1LP34:Brazil GLPG:Austria

Address

Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800

Website

https://www.glpg.com

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.